040-000-528 Erlotinib HCl

SKU: 040-000-528 Category:
Get A Quote






  I would like to join the mailing list to receive updates from Stanford Chemicals.
*: e-mail address with your company's domain name is preferred. Otherwise, we may not be able to process your inquiry.

Type Active Pharmaceutical ingredient
Synonym 774 hydrochloride, Erlotinib Hydrochloride
CAS No. 183319-69-9
Chemical Formula C22H23N3O4 · HCl
Appearance white powder
Packaging 250mg, 500mg, 1g, 5g, 10g
Assay ≥98%
Related Products Valsartan, Irbesartan, Olmesartan Medoxomil
Description

Description

Erlotinib HCl Introduction

Erlotinib HCl is a small molecule reversible inhibitor of epidermal growth factor receptor tyrosine kinase, which is mainly used for the second-line or third-line treatment of locally advanced or metastatic non-small cell lung cancer and pancreatic cancer.

Erlotinib targets the epidermal growth factor receptor subtype (EGFR-TK) that reversibly and selectively acts on the tyrosine kinase receptor, and its mechanism of action is to compete with substrates in cells and inhibit the phosphorylation of EGFR-TK , block the signal transduction of tumor cells, inhibit the growth of tumor cells, and induce their apoptosis. Clinical studies have shown that the drug has inhibitory effects on a variety of tumors. Compared with traditional chemotherapy drugs, it has the advantages of fewer adverse reactions, and better safety and tolerance.

Erlotinib HCl Specification

Appearance white powder
Melting Point 223-225℃
Content 98.0%
Storage Condition 2-8℃
Packaging 250mg, 500mg, 1g, 5g, 10g

 

Erlotinib HCl Applications

Erlotinib HCl is a small molecule reversible inhibitor of epidermal growth factor receptor tyrosine kinase, which is mainly used for the second-line or third-line treatment of locally advanced or metastatic non-small cell lung cancer and pancreatic cancer.